119 related articles for article (PubMed ID: 37848355)
21. Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice.
Mendenhall MA; Guinigundo A; Davies D; Ward P; Drosick DR; Waterhouse DM
JCO Oncol Pract; 2024 Feb; 20(2):262-267. PubMed ID: 37369093
[TBL] [Abstract][Full Text] [Related]
22. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
[TBL] [Abstract][Full Text] [Related]
23. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
Chang J; Seng S; Yoo J; Equivel P; Lum SS
Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
[TBL] [Abstract][Full Text] [Related]
24. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions.
Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA
J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961
[TBL] [Abstract][Full Text] [Related]
25. Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.
Jones T; Trivedi MS; Jiang X; Silverman T; Underhill M; Chung WK; Kukafka R; Crew KD
J Cancer Educ; 2021 Jun; 36(3):463-469. PubMed ID: 31802423
[TBL] [Abstract][Full Text] [Related]
26. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD
Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906
[TBL] [Abstract][Full Text] [Related]
27. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.
Green MJ; Biesecker BB; McInerney AM; Mauger D; Fost N
Am J Med Genet; 2001 Sep; 103(1):16-23. PubMed ID: 11562929
[TBL] [Abstract][Full Text] [Related]
28. Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon's practice in a large US Academic Center.
Chai TS; Yin K; Wooters M; Shannon KM; Hughes KS
Fam Cancer; 2023 Oct; 22(4):467-474. PubMed ID: 37354306
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
[TBL] [Abstract][Full Text] [Related]
30. A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women.
Loving VA; Luiten RC; Siettmann JM; Mina LA
Acad Radiol; 2022 Jan; 29 Suppl 1():S239-S245. PubMed ID: 33339730
[TBL] [Abstract][Full Text] [Related]
31. Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.
Erali RA; Pu T; Vu TM; Mangieri CW; Jee Y; Wise JS; Perry KC; Hsu FC; Levine EA; McNatt MH; Chiba A
Am Surg; 2023 Dec; 89(12):5842-5849. PubMed ID: 37183417
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
Alimena S; Scarpetti L; Blouch EL; Rodgers L; Shannon K; Del Carmen M; Goodman A; Growdon WB; Eisenhauer E; Sisodia RC
Int J Gynecol Cancer; 2020 Sep; 30(9):1397-1403. PubMed ID: 32447294
[TBL] [Abstract][Full Text] [Related]
33. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
[TBL] [Abstract][Full Text] [Related]
34. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X
Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751
[TBL] [Abstract][Full Text] [Related]
35. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial.
Gornick MC; Kurian AW; An LC; Fagerlin A; Jagsi R; Katz SJ; Hawley ST
Cancer; 2018 Oct; 124(20):4000-4009. PubMed ID: 30289174
[TBL] [Abstract][Full Text] [Related]
36. Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
Frost AS; Toaff M; Biagi T; Stark E; McHenry A; Kaltman R
Obstet Gynecol; 2018 Jun; 131(6):1103-1110. PubMed ID: 29742654
[TBL] [Abstract][Full Text] [Related]
37. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
38. Genetic counselor approaches to BRCA1/2 direct-to-consumer genetic testing results.
Burke S; Mork M; Qualmann K; Woodson A; Jin Ha M; Arun B; Kaulfus M
J Genet Couns; 2021 Jun; 30(3):803-812. PubMed ID: 33550665
[TBL] [Abstract][Full Text] [Related]
39. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
Hinshaw JC; Zhao LP; Brimm JE; Payne TH; Hisama FM
J Genet Couns; 2021 Dec; 30(6):1591-1597. PubMed ID: 33881185
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.
Haneda E; Sato A; Suganuma N; Sebata Y; Okamoto S; Toda S; Kohagura K; Matsubara Y; Sugawara Y; Yamanaka T; Yamashita T; Shimizu S; Narimatsu H
Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
